Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

Clinical trial NCT03170544 · COMPLETED

Trial details

NCT number

NCT03170544

Sponsor

Merck Sharp & Dohme LLC

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-08-16

Primary completion

2018-11-08

Enrollment

69

View on ClinicalTrials.gov